Literature DB >> 17960573

Proteomic analysis of metacyclic trypomastigotes undergoing Trypanosoma cruzi metacyclogenesis.

A Parodi-Talice1, V Monteiro-Goes, N Arrambide, A R Avila, R Duran, A Correa, B Dallagiovanna, A Cayota, M Krieger, S Goldenberg, C Robello.   

Abstract

Trypanosoma cruzi, the causative agent of the Chagas disease, has a complex life cycle alternating between replicative and noninfective forms with nonreplicative and infective forms of the parasite. Metacyclogenesis is a process that takes place in the invertebrate host, comprising morphogenetic transformation from a noninfective form to an infective form, such that parasites acquire the ability to invade human cells. We analyze here the metacyclogenesis process by 2D electrophoresis coupled to MALDI-TOF MS. A large proportion of unique proteins expressed during metacyclogenesis were observed. Interestingly, 50% of the spots were found to differ between epimastigotes and trypomastigotes. We provide a 2D map of the infective metacyclic trypomastigotes. Sixty six protein spots were successfully identified corresponding to 43 different proteins. We analyzed the expression profiles for the identified proteins along metacyclogenesis and classified them into three groups according to their maximal level of expression. We detected several isoforms for a number of proteins, some displaying differential expression during metacyclogenesis. These results suggest that posttranslational modifications may be a fundamental part of the parasite's strategy for regulating gene expression during differentiation. This study contributes to the identification of relevant proteins involved in the metacyclogenesis process. The identification and molecular characterization of these proteins will render vital information about the steps of the parasite differentiation into the infective form. Copyright 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17960573     DOI: 10.1002/jms.1267

Source DB:  PubMed          Journal:  J Mass Spectrom        ISSN: 1076-5174            Impact factor:   1.982


  36 in total

Review 1.  Mechanisms of Trypanosoma cruzi persistence in Chagas disease.

Authors:  Fnu Nagajyothi; Fabiana S Machado; Barbara A Burleigh; Linda A Jelicks; Philipp E Scherer; Shankar Mukherjee; Michael P Lisanti; Louis M Weiss; Nisha J Garg; Herbert B Tanowitz
Journal:  Cell Microbiol       Date:  2012-02-24       Impact factor: 3.715

2.  Stationary phase in Trypanosoma cruzi epimastigotes as a preadaptive stage for metacyclogenesis.

Authors:  Roberto Hernández; Ana María Cevallos; Tomás Nepomuceno-Mejía; Imelda López-Villaseñor
Journal:  Parasitol Res       Date:  2012-05-31       Impact factor: 2.289

Review 3.  Pathogenesis of chagas' disease: parasite persistence and autoimmunity.

Authors:  Antonio R L Teixeira; Mariana M Hecht; Maria C Guimaro; Alessandro O Sousa; Nadjar Nitz
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

Review 4.  Trypanosoma cruzi antioxidant enzymes as virulence factors in Chagas disease.

Authors:  Lucía Piacenza; Gonzalo Peluffo; María Noel Alvarez; Alejandra Martínez; Rafael Radi
Journal:  Antioxid Redox Signal       Date:  2012-05-21       Impact factor: 8.401

5.  Evaluation of the immune response against Trypanosoma cruzi cytosolic tryparedoxin peroxidase in human natural infection.

Authors:  Magalí C Girard; Gonzalo R Acevedo; Lucía López; Micaela S Ossowski; María D Piñeyro; Juan P Grosso; Marisa Fernandez; Yolanda Hernández Vasquez; Carlos Robello; Karina A Gómez
Journal:  Immunology       Date:  2018-08-03       Impact factor: 7.397

6.  Trypanothione synthetase confers growth, survival advantage and resistance to anti-protozoal drugs in Trypanosoma cruzi.

Authors:  Andrea C Mesías; Natalia Sasoni; Diego G Arias; Cecilia Pérez Brandán; Oliver C F Orban; Conrad Kunick; Carlos Robello; Marcelo A Comini; Nisha J Garg; M Paola Zago
Journal:  Free Radic Biol Med       Date:  2018-10-23       Impact factor: 7.376

7.  The steady-state transcriptome of the four major life-cycle stages of Trypanosoma cruzi.

Authors:  Todd A Minning; D Brent Weatherly; James Atwood; Ron Orlando; Rick L Tarleton
Journal:  BMC Genomics       Date:  2009-08-07       Impact factor: 3.969

8.  TcI Isolates of Trypanosoma cruzi Exploit the Antioxidant Network for Enhanced Intracellular Survival in Macrophages and Virulence in Mice.

Authors:  María Paola Zago; Yashoda M Hosakote; Sue-Jie Koo; Monisha Dhiman; María Dolores Piñeyro; Adriana Parodi-Talice; Miguel A Basombrio; Carlos Robello; Nisha J Garg
Journal:  Infect Immun       Date:  2016-05-24       Impact factor: 3.441

9.  Proteomic analysis of detergent-solubilized membrane proteins from insect-developmental forms of Trypanosoma cruzi.

Authors:  Esteban M Cordero; Ernesto S Nakayasu; Luciana G Gentil; Nobuko Yoshida; Igor C Almeida; José Franco da Silveira
Journal:  J Proteome Res       Date:  2009-07       Impact factor: 4.466

10.  Enzymes of the antioxidant network as novel determiners of Trypanosoma cruzi virulence.

Authors:  L Piacenza; M P Zago; G Peluffo; M N Alvarez; M A Basombrio; R Radi
Journal:  Int J Parasitol       Date:  2009-06-06       Impact factor: 3.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.